| |
| Issue |
Title |
| |
| Vol 13, No 3 (2020) |
Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making |
Abstract
PDF (Rus)
|
|
V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy |
| |
| Vol 13, No 3 (2020) |
Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov |
| |
| Vol 13, No 3 (2020) |
The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation |
Abstract
PDF (Rus)
|
|
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova |
| |
| Vol 13, No 3 (2020) |
Parameters for evaluating the main indicators of coloproctological care in the adult population in the subjects of the far Eastern Federal District in 2016–2018 |
Abstract
PDF (Rus)
|
|
A. V. Veselov, V. V. Omelyanosvkiy, Yu. A. Shelygin, A. V. Vitko, V. N. Kashnikov, N. V. Tashkinov, T. V. Shkurko, A. I. Moskalev, A. A. Serbina |
| |
| Vol 13, No 3 (2020) |
Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up |
Abstract
PDF (Rus)
|
|
L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko |
| |
| Vol 13, No 3 (2020) |
The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups |
Abstract
PDF (Rus)
|
|
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan |
| |
| Vol 13, No 2 (2020) |
Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation |
Abstract
PDF (Rus)
|
|
S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva |
| |
| Vol 13, No 2 (2020) |
COVID-19 pandemic: protective role of vitamin D |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, G. Kh. Gabdulina |
| |
| Vol 13, No 2 (2020) |
Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, N. P. Vanchakova, A. N. Galustyan, Zh. D. Kobalava, T. R. Grishina, A. N. Gromov, I. A. Ilovaiskaya, V. M. Kodentsova, A. G. Kalacheva, O. A. Limanova, V. A. Maksimov, S. I. Malyavskaya, E. V. Mozgovaya, N. I. Tapilskaya, K. V. Rudakov, V. A. Semenov |
| |
| Vol 13, No 2 (2020) |
Biological effects of phytoestrogens: clinical effectiveness and potential application in the treatment of climacteric syndrome |
Abstract
PDF (Rus)
|
|
M. A. Chernyavskaya, I. A. Narkevich |
| |
| Vol 13, No 2 (2020) |
Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova |
| |
| Vol 13, No 2 (2020) |
Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan |
| |
| Vol 12, No 4 (2019) |
Clinical and economic analysis of drug costs in a general hospital in 2014-2018 |
Abstract
PDF (Rus)
|
|
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova |
| |
| Vol 12, No 4 (2019) |
Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation |
Abstract
PDF (Rus)
|
|
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev |
| |
| Vol 12, No 4 (2019) |
Crucial areas of the economic analysis of public cancer care |
Abstract
PDF (Rus)
|
|
D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova |
| |
| Vol 12, No 4 (2019) |
Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis |
Abstract
PDF (Rus)
|
|
I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva |
| |
| Vol 12, No 4 (2019) |
Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev |
| |
| Vol 12, No 4 (2019) |
Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer |
Abstract
PDF (Rus)
|
|
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov |
| |
| Vol 12, No 2 (2019) |
Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers |
Abstract
PDF (Rus)
|
|
E. V. Radchenko, A. S. Kolbin |
| |
| Vol 12, No 2 (2019) |
Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova |
| |
| Vol 12, No 2 (2019) |
Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU |
Abstract
PDF (Rus)
|
|
G. N. Gildeeva, A. V. Belostotsky |
| |
| 151 - 171 of 171 Items |
<< < 1 2 3 4
|
